Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Am J Obstet Gynecol. 2021 Apr 21;225(3):285.e1–285.e7. doi: 10.1016/j.ajog.2021.04.235

Table 3.

Odds ratios for maternal and neonatal outcomes by embryo biopsy status

Outcome Adjusted ORb 95% CI P-valuea

Preeclampsia/ 1 Reference 0.5685
Eclampsia 0.82 (0.42-1.61)

Pregnancy Induced 1 Reference 0.6146
Hypertension 0.85 (0.46-1.59)

Prolonged stay 1 Reference 0.3041
(Maternal) 1.23 (0.83-1.80)

Prolonged stay 1 Reference 0.3923
(Infant) 1.29 (0.72-2.29)

Placental abnormalities 1 Reference 0.6675
1.16 (0.60-2.24)

Gestational diabetes 1 Reference 0.4734
0.83 (0.50-1.38)

Cesarean section 1 Reference 0.7762
1.04 (0.79-1.38)

Preterm birth 1 Reference 0.4418
1.22 (0.73-2.03)

Low birth weight 1 Reference 0.7355
1.12 (0.58-2.15)
a

Models are adjusted for mother’s age, race, education, parity, BMI, male infertility, endometriosis, PCOS, ovulatory disorder, diminished ovarian reserve, uterine factor, tubal factor, other, and unexplained diagnoses.

b

No biopsy group is the reference group.